Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Metoclopramide hydrochloride 10 mg oral tablet |
Is a |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Is a |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid 15 mg tablet med modificeret udløsning |
Is a |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid kapsel med modificeret udløsning a 15 mg |
Is a |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
Metoclopramide hydrochloride 5 mg oral tablet |
Is a |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid 1 mg/ml pædiatrisk oral opløsning |
Is a |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid 5 mg/5 ml sukkerfri oral opløsning |
Is a |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
Metoclopramide-containing product in parenteral dose form |
Is a |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochloridprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
Metoclopramide hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid 5 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid 15 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid kapsel med modificeret udløsning a 15 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
Metoclopramide hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid 1 mg/ml pædiatrisk oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid 5 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid 5 mg/5 ml sukkerfri oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
Product containing metoclopramide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
Metoclopramide-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
metoclopramidhydrochlorid 5 mg/ml infusionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|
Metoclopramide hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide hydrochloride 15 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide hydrochloride 15 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 15 mg prolonged-release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 15 mg prolonged-release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
2 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely metoclopramide hydrochloride 10 milligram/2 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide hydrochloride 10 milligram/2 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely metoclopramide hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide (as metoclopramide hydrochloride) 10 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide (as metoclopramide hydrochloride) 5 mg orodispersible tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride 5 mg and paracetamol 500 mg effervescent powder for oral suspension sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide (as metoclopramide hydrochloride) 5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
1 |
Metoclopramide hydrochloride anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Metoclopramide hydrochloride |
Inferred relationship |
Some |
|